Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 22, 2001

View Archived Issues

Small-molecule drug candidates jointly pursued by Morphochem and ACI

Canadian approval for BioCurex's cancer diagnostic kit

KS Biomedix makes significant progress over past year

Entomed and Shanghai Institute collaborate on insect biodiversity

Pilot Therapeutics gains license for oral retinoids

SynX and Princeton BioMeditech initiate diagnostics collaboration

Refractory tics in children with Tourette's syndrome improve on donepezil

Children with cerebral palsy treated with modafinil show improvement in spasticity

Genentech reports product development update for Q3 2001

Cerebral palsy-associated sialorrhea treated with botulinum toxin A

Inhibition of TNF-alpha activity results in improvement in baboons with experimental endometriosis

Remicade receives Canadian approval for rheumatoid arthritis indication

Angiotensin II stimulates human sperm motility; losartan antagonizes this effect

Effects on osteoclast and bone metastatic tumor cell functions of Src inhibitors

CPMP recommends approval of Gilead's Viread for HIV infection

Ara-CBP: effects on human osteoblasts and breast cancer cells described at ASBMR meeting

Adenovirus-mediated VEGF-A gene therapy enhances bone formation in animal model

Interim findings presented for phase I clinical trials of J591 for prostate cancer

New antiepileptic drug SPD-421 advances through development pipeline

CPMP issues positive opinion regarding MabThera for treatment of aggressive NHL

Basidiomycete found to produce new cytokine inhibitors CJ-14877 and CJ-14897

Yamanouchi presents new inhibitors of CRACC and IL-2 production

Amide 5-HT antagonists and their uses described in recent patent

MMP inhibitors claimed by AstraZeneca for arthritis, atherosclerosis and COPD

CV Therapeutics discovers several series of partial fatty acid oxidation inhibitors

Chemokine receptor modulators designed by AstraZeneca team

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...